HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma
Methodology, Interpretation, and Significance
Contact Information
March 2012
Thank you.
Contact Information |
Jump to section:
- Objectives
- Outline
- Oropharyngeal Squamous Cell Carcinoma in Review
- Oropharynx Anatomy
- Epidemiology of OPSCC — Demographics
- Epidemiology of OPSCC — Incidence
- Management Strategies in OPSCC
- The Role of HPV and p16 in Oropharyngeal Squamous Cell Carcinoma
- Human Papillomavirus (HPV)
- HPV in OPSCC Oncogenesis — Genome
- HPV in OPSCC Oncogenesis — Pathways
- HPV in OPSCC Oncogenesis — Detection
- Indications for HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma
- Prognostic
- Prognostic
- Prognostic
- Diagnostic
- Interpretation of HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma
- Interpret the Presence or Absence of HPV
- Don't Jump the Gun
- Polymerase Chain Reaction (PCR)
- DNA In Situ Hybridization
- E6/E7 Messenger Ribonucleic Acid (mRNA)
- P16 Immunohistochemistry
- HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma in Review
- Review
- Contact Information
- References
- References
- Questions
External
link
PDF
document
Excel
document
Word
document